Cargando…
C/EBPβ cooperates with MYB to maintain the oncogenic program of AML cells
Studies on the role of transcription factor MYB in acute myeloid leukemia (AML) have identified MYB as a key regulator of a transcriptional program for self-renewal of AML cells. Recent work summarized here has now highlighted the CCAAT-box/enhancer binding protein beta (C/EBPβ) as an essential fact...
Autor principal: | Klempnauer, Karl-Heinz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010626/ https://www.ncbi.nlm.nih.gov/pubmed/36913305 http://dx.doi.org/10.18632/oncotarget.28377 |
Ejemplares similares
-
Natural Products with Antitumor Potential Targeting the MYB-C/EBPβ-p300 Transcription Module
por: Schmidt, Thomas J., et al.
Publicado: (2022) -
C/EBPβ is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia
por: Yusenko, Maria V., et al.
Publicado: (2021) -
The natural anti-tumor compound Celastrol targets a Myb-C/EBPβ-p300 transcriptional module implicated in myeloid gene expression
por: Coulibaly, Anna, et al.
Publicado: (2018) -
Oncogenic point mutations in the Myb DNA-binding domain alter the DNA-binding properties of Myb at a physiological target gene
por: Ivanova, Olga, et al.
Publicado: (2007) -
Activation of the oncogenic transcription factor B-Myb via multisite phosphorylation and prolyl cis/trans isomerization
por: Werwein, Eugen, et al.
Publicado: (2019)